Chronic Rhinosinusitis Clinical Trial
Official title:
Determinants of Surgical Outcomes in Chronic Sinusitis
Chronic rhinosinusitis (CRS) is a common health condition in the United States resulting in
more than 200,000 surgical procedures annually. The field of rhinology has had two major
advances which the investigators believe make more accurate prediction of postoperative
outcome possible thereby offering the potential of reducing the frequency of unsuccessful
surgical procedures. The first advance is the development of validated disease-specific
quality of life instruments for measuring outcome of CRS management. The major medical
societies now recognize disease-specific quality of life as the gold standard for assessing
outcomes in this disease and for the purposes of this study, the investigators define
surgical outcome as change in disease-specific quality of life (QOL). The second advance is
the better understanding of the pathological process resulting in CRS. The previous
construct defined this disease as anatomic obstruction of the sinuses and their secretions.
This was thought to be best measured by CT scan which has been the main method of attempting
to select the best candidates for surgery.
The investigators hypothesize that utilizing this new conceptual framework, the
investigators can better predict surgical outcomes. The investigators will examine several
preoperative factors and their relationship to surgical outcome. The factors to be examined
include measures of the pathophysiological components of inflammation and anatomic
obstruction as well as preoperative extent of disease as measured by preoperative
disease-specific quality of life. The investigators hypothesize that these factors provide
complimentary information that may be variably expressed in individual CRS patients.
Therefore, the investigators hypothesize that a novel integration of multiple preoperative
factors will form a useful predictive model of surgical outcome. Finally this prospective
study provides the opportunity to add to the field by identifying potentially novel risk
factors and comorbidities as well as study secondary outcomes of sinus surgery including
olfactory function and general health related quality of life in a systematic manner.
A cohort of 500+ patients with CRS undergoing sinus surgery at three centers will be
prospectively enrolled. Patient demographics, comorbidity data, objective testing, and QOL
evaluation will occur preoperatively and outcomes (QOL and olfactory testing) will be
measured 6, 12, and 18 months postoperatively. Determinants of change in QOL will be
analyzed by univariate and multivariate methods including construction of a multivariate
predictive model.
This proposal focuses on patients undergoing surgical intervention for the management of
CRS. The findings can potentially be applied to the 200,000 patients annually undergoing
sinus surgery and in working toward the long-term goal of developing a comprehensive system
for measuring extent of disease so that disease severity and treatment response can be
rigorously quantified in the 30 million patients with CRS.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04131686 -
NAC Inhalation in the Treatment Of Symptomatic acuTe rhinosinUSitis
|
||
Completed |
NCT02692794 -
Large Scale Cerebral Oximetry During Sinus Endoscopy
|
N/A | |
Completed |
NCT01988779 -
Oral Versus Topical Antibiotics for Chronic Rhinosinusitis Exacerbations
|
Phase 3 | |
Completed |
NCT01254916 -
The Sinonasal Outcome Test - 22, Validated for Danish Patients
|
N/A | |
Completed |
NCT03614923 -
Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
|
Phase 2 | |
Completed |
NCT03781804 -
Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal Polyps
|
Phase 3 | |
Completed |
NCT01198912 -
Influence of Oral Doxycycline on Wound Healing After Endonasal Endoscopic Sinus Surgery for Chronic Rhinosinusitis With and Without Nasal Polyposis: a Double-blind Randomized Placebo-controlled Trial
|
Phase 2 | |
Active, not recruiting |
NCT06457100 -
Esmolol Versus Lidocaine on the Quality of Postoperative Recovery in Patients Undergoing Functional Endoscopic Sinus Surgery
|
Phase 1/Phase 2 | |
Completed |
NCT03280537 -
A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps
|
Phase 3 | |
Completed |
NCT02307825 -
Azithromycin for Patients With Chronic Rhinosinusitis Failing Medical and Surgical Therapy
|
Phase 4 | |
Terminated |
NCT02285283 -
Itraconazole for Fungal Sensitive Chronic Rhinosinusitis With Nasal Polyps
|
Phase 2/Phase 3 | |
Completed |
NCT02218307 -
The Use of Antibiotic Sinonasal Rinse After Sinus Surgery
|
Phase 4 | |
Recruiting |
NCT01024075 -
Effect of Sinufoam-Dexamethasone Mixture on Post Endoscopic Sinus Surgery Outcomes
|
Phase 4 | |
Completed |
NCT01002313 -
Effect of Prednisone onTregs and TH17
|
Phase 1 | |
Completed |
NCT00396162 -
Use of Probiotics as Adjunctive Treatment for Chronic Rhinosinusitis
|
Phase 4 | |
Completed |
NCT03280550 -
A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps
|
Phase 3 | |
Recruiting |
NCT05935683 -
Rhinosinusitis Italian Network: the Italian Registry for Severe, Uncontrolled Chronic Rhinosinusitis
|
||
Completed |
NCT03478930 -
An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps
|
Phase 3 | |
Completed |
NCT01943370 -
Early Saline Irrigation to Decrease Post-operative Endoscopic Debridement
|
N/A | |
Completed |
NCT02154555 -
A Randomized Controlled Trial Evaluating Postoperative Debridement Following Endoscopic Sinus Surgery
|
N/A |